Chicago Drug Company meets trial goal for new drug
Chicago area drug company Advanced Life Sciences Holding Inc. has successfully completed primary trial goal for a new one dose drug for pneumonia treatment. A thirty day course of the drug was also 100% effective against a lethal dose of inhaled anthrax. The drug, cethromycin, met the trial goal set by another long-acting antibiotic, clarithromycin, with similar safety risks.
Click here for the full article
Bookmark: 
